Related Experiment Video
Updated: Apr 16, 2026

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
Published on: August 23, 2016
[Interferon-free treatment for patients with chronic hepatitis C]
Abstract:
Oral combinations of direct acting antivirals (interferon-free) improve efficacy and safety outcomes for patients with hepatitis C virus (HCV) infection. In Japanese phase 3 study of daclatasvir plus asunaprevir combination therapy for 24 weeks, 222 patients with chronic HCV genotype 1b infection were enrolled. SVR was achieved by 87% of interferon-ineligible/intolerant patients and 81% of nonresponder patients; rates were similar in cirrhosis (91%) and noncirrhosis (84%) patients, and in patients with IL28B CC (85%) or non-CC (85%) genotypes. The rate of serious adverse events was low among patients. Other oral combination therapies (interferon-free) are ongoing in Japan. Interferon-free all-oral therapy is well tolerated and can achieve a high rate of SVR in patients with HCV genotype 1b.
More Related Videos
07:25Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
06:28Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
Published on: October 1, 2015
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Hepatitis
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Retrovirus Life Cycles
Treatment Resistent Cancers
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF